25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MBXBF (Microbix) Stock Analysis
Buy, Hold or Sell?

Let's analyze Microbix together

I guess you are interested in Microbix Biosystems Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Microbix’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Microbix’s Price Targets

I'm going to help you getting a better view of Microbix Biosystems Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Microbix Biosystems Inc.

I send you an email if I find something interesting about Microbix Biosystems Inc..

1. Quick Overview

1.1. Quick analysis of Microbix (30 sec.)










1.2. What can you expect buying and holding a share of Microbix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.16
Expected worth in 1 year
$0.18
How sure are you?
65.0%

+ What do you gain per year?

Total Gains per Share
$0.02
Return On Investment
7.6%

For what price can you sell your share?

Current Price per Share
$0.22
Expected price per share
$0.171 - $0.24
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Microbix (5 min.)




Live pricePrice per Share (EOD)
$0.22
Intrinsic Value Per Share
$0.09 - $0.11
Total Value Per Share
$0.25 - $0.27

2.2. Growth of Microbix (5 min.)




Is Microbix growing?

Current yearPrevious yearGrowGrow %
How rich?$22.6m$18.6m$2.5m12.1%

How much money is Microbix making?

Current yearPrevious yearGrowGrow %
Making money$285.7k$741.7k-$456k-159.6%
Net Profit Margin6.6%17.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Microbix (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#496 / 872

Most Revenue
#366 / 872

Most Profit
#158 / 872

Most Efficient
#137 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Microbix?

Welcome investor! Microbix's management wants to use your money to grow the business. In return you get a share of Microbix.

First you should know what it really means to hold a share of Microbix. And how you can make/lose money.

Speculation

The Price per Share of Microbix is $0.2163. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Microbix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Microbix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.16. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Microbix.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%0.000.9%0.012.4%0.000.7%0.000.4%0.00-0.5%
Usd Book Value Change Per Share0.014.9%0.001.9%0.012.6%0.001.4%0.002.3%0.001.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.014.9%0.001.9%0.012.6%0.001.4%0.002.3%0.001.2%
Usd Price Per Share0.29-0.26-0.27-0.29-0.33-0.26-
Price to Earnings Ratio689.55-194.24-7.06-63.92-50.00-28.69-
Price-to-Total Gains Ratio27.93-114.80-16.48-31.90-32.09--332.52-
Price to Book Ratio1.83-1.76-2.06-2.16-3.68-3.43-
Price-to-Total Gains Ratio27.93-114.80-16.48-31.90-32.09--332.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2163
Number of shares4623
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (4623 shares)19.0222.73
Gains per Year (4623 shares)76.0690.93
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10766609181
201521420182172
302282180273263
403042940364354
503803700455445
604564460546536
705325220637627
806085980727718
906856740818809
1007617500909900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%14.06.00.070.0%23.016.01.057.5%40.016.043.040.4%
Book Value Change Per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%26.014.00.065.0%58.041.00.058.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.099.00.0%
Total Gains per Share4.00.00.0100.0%9.03.00.075.0%15.05.00.075.0%26.014.00.065.0%58.041.00.058.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Microbix Biosystems Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0110.004+156%0.006+85%0.003+243%0.005+114%0.003+291%
Book Value Per Share--0.1600.150+7%0.132+21%0.136+18%0.111+44%0.086+85%
Current Ratio--9.3607.437+26%6.172+52%6.945+35%5.472+71%3.199+193%
Debt To Asset Ratio--0.2110.248-15%0.294-28%0.271-22%0.332-36%0.375-44%
Debt To Equity Ratio--0.2680.330-19%0.419-36%0.374-28%0.550-51%0.639-58%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--35569871.92730366776.201+17%30559116.153+16%33735376.719+5%40206984.212-12%33149975.078+7%
Eps--0.0000.002-95%0.005-98%0.002-93%0.001-87%-0.001+1058%
Ev To Sales Ratio--2.2861.838+24%1.821+26%2.412-5%3.012-24%3.648-37%
Free Cash Flow Per Share--0.0040.003+28%0.002+56%0.001+185%0.001+266%0.001+408%
Free Cash Flow To Equity Per Share--0.0080.002+258%0.001+416%0.001+1385%0.003+137%0.003+146%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--0.111----------
Intrinsic Value_10Y_min--0.094----------
Intrinsic Value_1Y_max--0.006----------
Intrinsic Value_1Y_min--0.006----------
Intrinsic Value_3Y_max--0.022----------
Intrinsic Value_3Y_min--0.021----------
Intrinsic Value_5Y_max--0.043----------
Intrinsic Value_5Y_min--0.039----------
Market Cap30505221.600-37%41641113.36037347390.340+11%38290188.000+9%40820067.447+2%47178447.988-12%36725649.634+13%
Net Profit Margin--0.0040.066-94%0.172-98%0.038-90%-0.028+818%-0.120+3187%
Operating Margin----0%-0.0300%-0.0420%0.041-100%0.026-100%
Operating Ratio--1.3711.338+2%1.485-8%1.463-6%1.388-1%1.285+7%
Pb Ratio1.350-36%1.8351.755+5%2.065-11%2.156-15%3.683-50%3.426-46%
Pe Ratio507.315-36%689.554194.244+255%7.060+9667%63.922+979%50.002+1279%28.688+2304%
Price Per Share0.216-36%0.2940.265+11%0.272+8%0.289+2%0.334-12%0.260+13%
Price To Free Cash Flow Ratio14.530-36%19.75023.223-15%19.408+2%11.329+74%4.944+299%2.263+773%
Price To Total Gains Ratio20.545-36%27.925114.795-76%16.485+69%31.899-12%32.093-13%-332.520+1291%
Quick Ratio--0.8971.125-20%1.035-13%1.030-13%0.923-3%0.573+57%
Return On Assets--0.0010.010-95%0.028-98%0.010-95%-0.002+429%-0.015+2956%
Return On Equity--0.0010.014-95%0.038-98%0.013-95%-0.016+2446%-0.034+5144%
Total Gains Per Share--0.0110.004+156%0.006+85%0.003+243%0.005+114%0.003+291%
Usd Book Value--22696047.35621239429.314+7%18675913.915+22%19180977.939+18%15699113.731+45%12192672.044+86%
Usd Book Value Change Per Share--0.0110.004+156%0.006+85%0.003+243%0.005+114%0.003+291%
Usd Book Value Per Share--0.1600.150+7%0.132+21%0.136+18%0.111+44%0.086+85%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--35569871.92730366776.201+17%30559116.153+16%33735376.719+5%40206984.212-12%33149975.078+7%
Usd Eps--0.0000.002-95%0.005-98%0.002-93%0.001-87%-0.001+1058%
Usd Free Cash Flow--527101.598410669.164+28%337132.996+56%184183.712+186%143361.985+268%54297.334+871%
Usd Free Cash Flow Per Share--0.0040.003+28%0.002+56%0.001+185%0.001+266%0.001+408%
Usd Free Cash Flow To Equity Per Share--0.0080.002+258%0.001+416%0.001+1385%0.003+137%0.003+146%
Usd Market Cap30505221.600-37%41641113.36037347390.340+11%38290188.000+9%40820067.447+2%47178447.988-12%36725649.634+13%
Usd Price Per Share0.216-36%0.2940.265+11%0.272+8%0.289+2%0.334-12%0.260+13%
Usd Profit--15097.118285791.724-95%741791.696-98%275968.686-95%144555.493-90%-129361.015+957%
Usd Revenue--3890345.6384150215.127-6%4353493.070-11%3812384.469+2%3527009.893+10%2653100.430+47%
Usd Total Gains Per Share--0.0110.004+156%0.006+85%0.003+243%0.005+114%0.003+291%
 EOD+4 -4MRQTTM+22 -13YOY+24 -113Y+23 -125Y+22 -1410Y+31 -6

3.3 Fundamental Score

Let's check the fundamental score of Microbix Biosystems Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15507.315
Price to Book Ratio (EOD)Between0-11.350
Net Profit Margin (MRQ)Greater than00.004
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.897
Current Ratio (MRQ)Greater than19.360
Debt to Asset Ratio (MRQ)Less than10.211
Debt to Equity Ratio (MRQ)Less than10.268
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Microbix Biosystems Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.654
Ma 20Greater thanMa 500.221
Ma 50Greater thanMa 1000.241
Ma 100Greater thanMa 2000.265
OpenGreater thanClose0.216
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Microbix Biosystems Inc.

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. It also provides customer vial filling services. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.

Fundamental data was last updated by Penke on 2025-06-30 17:36:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Microbix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Microbix to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.4%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 0.4%. The company is not making a profit/loss.
  • The TTM is 6.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM6.6%-6.2%
TTM6.6%YOY17.2%-10.6%
TTM6.6%5Y-2.8%+9.4%
5Y-2.8%10Y-12.0%+9.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4%-93.6%+94.0%
TTM6.6%-140.9%+147.5%
YOY17.2%-197.6%+214.8%
3Y3.8%-248.5%+252.3%
5Y-2.8%-343.4%+340.6%
10Y-12.0%-496.2%+484.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Microbix is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Microbix to theΒ Biotechnology industry mean.
  • 0.1% Return on Assets means thatΒ Microbix generatedΒ $0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Microbix Biosystems Inc.:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.1%TTM1.0%-1.0%
TTM1.0%YOY2.8%-1.8%
TTM1.0%5Y-0.2%+1.2%
5Y-0.2%10Y-1.5%+1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-11.6%+11.7%
TTM1.0%-11.6%+12.6%
YOY2.8%-11.4%+14.2%
3Y1.0%-11.8%+12.8%
5Y-0.2%-12.0%+11.8%
10Y-1.5%-13.7%+12.2%
4.3.1.3. Return on Equity

Shows how efficient Microbix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Microbix to theΒ Biotechnology industry mean.
  • 0.1% Return on Equity means Microbix generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Microbix Biosystems Inc.:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM1.4%-1.3%
TTM1.4%YOY3.8%-2.4%
TTM1.4%5Y-1.6%+2.9%
5Y-1.6%10Y-3.4%+1.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-13.5%+13.6%
TTM1.4%-14.9%+16.3%
YOY3.8%-14.6%+18.4%
3Y1.3%-16.8%+18.1%
5Y-1.6%-17.5%+15.9%
10Y-3.4%-19.9%+16.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Microbix Biosystems Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Microbix is operatingΒ .

  • Measures how much profit Microbix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Microbix to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Microbix Biosystems Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-3.0%+3.0%
TTM-5Y4.1%-4.1%
5Y4.1%10Y2.6%+1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.5%+250.5%
YOY-3.0%-209.2%+206.2%
3Y-4.2%-234.1%+229.9%
5Y4.1%-346.1%+350.2%
10Y2.6%-477.5%+480.1%
4.3.2.2. Operating Ratio

Measures how efficient Microbix is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are $1.37 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 1.371. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.338. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.371TTM1.338+0.033
TTM1.338YOY1.485-0.147
TTM1.3385Y1.388-0.050
5Y1.38810Y1.285+0.103
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3712.111-0.740
TTM1.3382.694-1.356
YOY1.4853.096-1.611
3Y1.4633.652-2.189
5Y1.3884.745-3.357
10Y1.2856.614-5.329
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Microbix Biosystems Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Microbix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 9.36Β means the company has $9.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 9.360. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.437. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.360TTM7.437+1.924
TTM7.437YOY6.172+1.265
TTM7.4375Y5.472+1.965
5Y5.47210Y3.199+2.273
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3603.661+5.699
TTM7.4373.846+3.591
YOY6.1724.140+2.032
3Y6.9454.688+2.257
5Y5.4725.746-0.274
10Y3.1996.147-2.948
4.4.3.2. Quick Ratio

Measures if Microbix is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Microbix to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.90Β means the company can pay off $0.90 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.897. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.125. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ0.897TTM1.125-0.228
TTM1.125YOY1.035+0.091
TTM1.1255Y0.923+0.202
5Y0.92310Y0.573+0.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8972.848-1.951
TTM1.1253.169-2.044
YOY1.0353.786-2.751
3Y1.0304.311-3.281
5Y0.9235.703-4.780
10Y0.5736.368-5.795
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Microbix Biosystems Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of MicrobixΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Microbix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.21Β means that Microbix assets areΒ financed with 21.1% credit (debt) and the remaining percentage (100% - 21.1%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.211. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.248. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.211TTM0.248-0.037
TTM0.248YOY0.294-0.046
TTM0.2485Y0.332-0.085
5Y0.33210Y0.375-0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2110.329-0.118
TTM0.2480.349-0.101
YOY0.2940.331-0.037
3Y0.2710.340-0.069
5Y0.3320.349-0.017
10Y0.3750.379-0.004
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Microbix is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Microbix to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 26.8% means that company has $0.27 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Microbix Biosystems Inc.:

  • The MRQ is 0.268. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.330. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.268TTM0.330-0.063
TTM0.330YOY0.419-0.089
TTM0.3305Y0.550-0.220
5Y0.55010Y0.639-0.089
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2680.379-0.111
TTM0.3300.437-0.107
YOY0.4190.414+0.005
3Y0.3740.450-0.076
5Y0.5500.464+0.086
10Y0.6390.515+0.124
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Microbix generates.

  • Above 15 is considered overpriced butΒ always compareΒ Microbix to theΒ Biotechnology industry mean.
  • A PE ratio of 689.55 means the investor is paying $689.55Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 507.315. Based on the earnings, the company is expensive. -2
  • The MRQ is 689.554. Based on the earnings, the company is expensive. -2
  • The TTM is 194.244. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD507.315MRQ689.554-182.239
MRQ689.554TTM194.244+495.310
TTM194.244YOY7.060+187.184
TTM194.2445Y50.002+144.242
5Y50.00210Y28.688+21.314
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD507.315-2.356+509.671
MRQ689.554-2.077+691.631
TTM194.244-2.574+196.818
YOY7.060-3.760+10.820
3Y63.922-3.773+67.695
5Y50.002-6.193+56.195
10Y28.688-6.876+35.564
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 14.530. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 19.750. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.223. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.530MRQ19.750-5.220
MRQ19.750TTM23.223-3.473
TTM23.223YOY19.408+3.814
TTM23.2235Y4.944+18.279
5Y4.94410Y2.263+2.681
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD14.530-3.246+17.776
MRQ19.750-2.705+22.455
TTM23.223-3.704+26.927
YOY19.408-4.402+23.810
3Y11.329-5.070+16.399
5Y4.944-8.477+13.421
10Y2.263-9.305+11.568
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Microbix is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.83 means the investor is paying $1.83Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Microbix Biosystems Inc.:

  • The EOD is 1.350. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.835. Based on the equity, the company is underpriced. +1
  • The TTM is 1.755. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.350MRQ1.835-0.485
MRQ1.835TTM1.755+0.080
TTM1.755YOY2.065-0.310
TTM1.7555Y3.683-1.928
5Y3.68310Y3.426+0.257
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3502.038-0.688
MRQ1.8351.843-0.008
TTM1.7552.125-0.370
YOY2.0652.442-0.377
3Y2.1562.492-0.336
5Y3.6833.652+0.031
10Y3.4264.311-0.885
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets39,375
Total Liabilities8,310
Total Stockholder Equity31,065
 As reported
Total Liabilities 8,310
Total Stockholder Equity+ 31,065
Total Assets = 39,375

Assets

Total Assets39,375
Total Current Assets25,946
Long-term Assets13,429
Total Current Assets
Cash And Cash Equivalents 14,539
Net Receivables 2,486
Inventory 8,275
Other Current Assets 618
Total Current Assets  (as reported)25,946
Total Current Assets  (calculated)25,918
+/- 27
Long-term Assets
Property Plant Equipment 9,454
Intangible Assets 3,975
Long-term Assets Other 0
Long-term Assets  (as reported)13,429
Long-term Assets  (calculated)13,429
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,772
Long-term Liabilities5,538
Total Stockholder Equity31,065
Total Current Liabilities
Short Long Term Debt 5
Total Current Liabilities  (as reported)2,772
Total Current Liabilities  (calculated)5
+/- 2,767
Long-term Liabilities
Long term Debt 4,718
Capital Lease Obligations Min Short Term Debt628
Long-term Liabilities Other 285
Long-term Liabilities  (as reported)5,538
Long-term Liabilities  (calculated)5,631
+/- 93
Total Stockholder Equity
Total Stockholder Equity (as reported)31,065
Total Stockholder Equity (calculated)0
+/- 31,065
Other
Capital Stock50,990
Common Stock Shares Outstanding 141,636
Net Invested Capital 35,788
Net Working Capital 23,174
Property Plant and Equipment Gross 19,677



6.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-09-302000-06-302000-03-31
> Total Assets 
1,851
1,935
1,925
1,971
2,067
1,881
1,725
1,673
1,781
1,715
1,954
1,958
2,180
2,201
2,096
2,304
2,306
2,674
2,914
3,062
3,396
3,549
4,254
4,409
3,547
3,267
3,482
5,765
5,852
11,965
11,251
11,208
13,719
11,590
11,554
11,987
13,177
12,788
14,094
12,696
13,907
13,426
17,520
17,608
13,152
13,258
14,001
13,180
13,752
12,832
12,798
12,166
12,334
11,712
13,570
15,011
16,072
16,214
17,346
17,801
17,685
17,002
18,569
19,424
19,230
18,518
19,413
20,211
21,135
21,868
26,866
28,180
19,310
19,928
20,304
20,322
19,630
19,756
20,692
20,485
15,598
16,287
17,956
25,864
28,829
31,226
32,947
33,296
33,145
32,694
33,194
34,295
35,653
36,707
37,922
37,733
38,097
39,299
39,375
39,37539,29938,09737,73337,92236,70735,65334,29533,19432,69433,14533,29632,94731,22628,82925,86417,95616,28715,59820,48520,69219,75619,63020,32220,30419,92819,31028,18026,86621,86821,13520,21119,41318,51819,23019,42418,56917,00217,68517,80117,34616,21416,07215,01113,57011,71212,33412,16612,79812,83213,75213,18014,00113,25813,15217,60817,52013,42613,90712,69614,09412,78813,17711,98711,55411,59013,71911,20811,25111,9655,8525,7653,4823,2673,5474,4094,2543,5493,3963,0622,9142,6742,3062,3042,0962,2012,1801,9581,9541,7151,7811,6731,7251,8812,0671,9711,9251,9351,851
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,752
4,236
4,403
4,926
5,191
5,843
6,959
6,067
6,793
7,330
7,387
6,452
6,161
7,094
6,700
6,493
7,136
8,840
16,805
19,094
21,548
23,127
23,476
22,408
22,066
22,309
23,499
22,302
23,701
24,683
23,918
24,260
25,694
25,946
25,94625,69424,26023,91824,68323,70122,30223,49922,30922,06622,40823,47623,12721,54819,09416,8058,8407,1366,4936,7007,0946,1616,4527,3877,3306,7936,0676,9595,8435,1914,9264,4034,2363,75200000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85
93
519
643
6,262
4,355
3,320
3,201
859
437
666
550
115
763
93
16
194
153
202
119
184
499
554
232
176
123
50
252
196
1,041
424
488
681
880
0
78
48
5
4
4
1
25
126
43
41
92
56
44
276
25
14
96
70
168
402
93
417
1,545
7,507
9,986
10,495
12,201
14,163
13,488
12,425
11,722
13,409
11,606
12,783
12,873
12,809
12,963
13,048
14,539
14,53913,04812,96312,80912,87312,78311,60613,40911,72212,42513,48814,16312,20110,4959,9867,5071,54541793402168709614252764456924143126251445487808806814884241,0411962525012317623255449918411920215319416937631155506664378593,2013,3204,3556,26264351993850000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
198
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000001980000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
970
1,162
783
1,189
1,376
1,038
2,028
1,406
1,078
1,854
1,849
1,777
1,257
2,008
1,304
1,887
1,896
2,124
4,180
4,206
5,591
4,578
2,518
3,089
2,895
3,128
3,403
4,120
3,807
4,408
4,013
4,161
4,920
2,486
2,4864,9204,1614,0134,4083,8074,1203,4033,1282,8953,0892,5184,5785,5914,2064,1802,1241,8961,8871,3042,0081,2571,7771,8491,8541,0781,4062,0281,0381,3761,1897831,16297000000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
28
27
30
61
73
58
54
62
55
21
34
80
68
34
29
37
38
36
43
67
66
45
62
104
64
54
96
93
78
64
859
134
124
100
99
71
106
59
123
86
97
88
121
108
169
52
95
101
151
102
99
68
74
83
275
345
246
241
145
333
163
91
71
53
43
46
67
86
122
75
93
172
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,825
0
0
0
0
767
911
1,209
770
643
623
618
6186236437701,20991176700006,825000000000000001701729375122866746435371911633331452412463452758374689910215110195521691081218897861235910671991001241348596478939654641046245666743363837293468803421556254587361302728
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,975
12,935
13,177
13,595
13,598
13,785
9,105
9,151
9,116
9,059
9,735
9,678
9,820
9,821
10,737
10,628
10,885
10,796
13,351
13,005
13,239
13,815
13,837
13,605
13,429
13,42913,60513,83713,81513,23913,00513,35110,79610,88510,62810,7379,8219,8209,6789,7359,0599,1169,1519,10513,78513,59813,59513,17712,93512,97500000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
994
947
906
830
863
819
789
770
796
745
751
796
846
849
864
857
831
872
900
951
1,100
1,273
1,429
1,448
1,571
1,526
1,526
1,734
1,841
1,777
1,929
3,970
4,353
4,965
5,321
5,971
6,359
6,473
6,676
6,306
6,498
6,625
6,710
6,657
6,079
6,188
6,290
6,073
6,238
6,112
5,928
5,669
5,750
5,594
5,750
7,086
7,815
8,430
9,249
10,175
8,913
8,688
9,360
9,446
9,332
9,090
9,141
9,494
9,763
10,180
12,861
13,090
6,647
6,573
6,539
6,534
6,650
7,103
7,139
7,361
7,363
7,443
7,388
7,368
8,083
8,064
8,245
8,284
8,906
8,835
9,131
9,081
8,928
8,697
9,046
9,474
9,618
9,508
9,454
9,4549,5089,6189,4749,0468,6978,9289,0819,1318,8358,9068,2848,2458,0648,0837,3687,3887,4437,3637,3617,1397,1036,6506,5346,5396,5736,64713,09012,86110,1809,7639,4949,1419,0909,3329,4469,3608,6888,91310,1759,2498,4307,8157,0865,7505,5945,7505,6695,9286,1126,2386,0736,2906,1886,0796,6576,7106,6256,4986,3066,6766,4736,3595,9715,3214,9654,3533,9701,9291,7771,8411,7341,5261,5261,5711,4481,4291,2731,100951900872831857864849846796751745796770789819863830906947994
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
240
234
229
235
230
217
214
228
1,697
1,662
1,591
1,577
4,092
3,561
3,417
3,685
4,004
4,047
4,169
3,954
4,067
4,156
4,248
4,252
3,895
3,971
4,063
3,935
4,050
4,002
3,866
3,721
3,767
3,635
3,783
4,041
3,619
3,501
3,190
3,347
4,026
4,175
4,530
4,655
4,725
4,723
4,962
5,095
5,183
5,238
6,582
6,551
5,016
4,982
4,947
4,912
4,959
4,924
4,890
4,855
1,742
1,707
0
0
1,652
0
0
0
1,498
0
0
0
4,423
4,308
4,193
4,341
4,219
4,097
3,975
3,9754,0974,2194,3414,1934,3084,4230001,4980001,652001,7071,7424,8554,8904,9244,9594,9124,9474,9825,0166,5516,5825,2385,1835,0954,9624,7234,7254,6554,5304,1754,0263,3473,1903,5013,6194,0413,7833,6353,7673,7213,8664,0024,0503,9354,0633,9713,8954,2524,2484,1564,0673,9544,1694,0474,0043,6853,4173,5614,0921,5771,5911,6621,69722821421723023522923424000000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
784
661
757
671
662
578
557
489
483
380
709
676
843
732
679
751
986
864
847
882
1,016
1,195
1,608
1,796
2,222
2,181
2,539
2,848
3,549
3,665
3,793
5,145
6,560
5,798
6,185
6,741
7,180
7,378
7,556
7,500
8,420
7,828
8,936
9,061
8,250
8,484
8,572
8,227
9,554
8,990
8,865
8,454
6,785
6,217
7,156
7,682
7,284
7,080
7,188
7,298
7,413
6,920
7,640
8,325
7,582
7,147
7,704
7,978
9,004
7,172
8,556
9,699
8,957
9,660
9,612
9,781
9,092
9,776
8,744
8,931
8,979
9,243
9,741
9,150
10,273
9,028
9,133
8,551
8,207
9,232
9,829
11,652
11,029
9,481
10,166
9,710
9,799
10,399
8,310
8,31010,3999,7999,71010,1669,48111,02911,6529,8299,2328,2078,5519,1339,02810,2739,1509,7419,2438,9798,9318,7449,7769,0929,7819,6129,6608,9579,6998,5567,1729,0047,9787,7047,1477,5828,3257,6406,9207,4137,2987,1887,0807,2847,6827,1566,2176,7858,4548,8658,9909,5548,2278,5728,4848,2509,0618,9367,8288,4207,5007,5567,3787,1806,7416,1855,7986,5605,1453,7933,6653,5492,8482,5392,1812,2221,7961,6081,1951,016882847864986751679732843676709380483489557578662671757661784
   > Total Current Liabilities 
318
230
558
529
400
483
471
410
425
348
359
335
471
519
453
334
572
422
376
407
456
539
626
766
922
660
745
874
950
1,057
1,232
1,060
2,129
1,870
1,648
1,547
1,554
1,565
1,499
1,704
2,466
1,586
2,487
2,603
2,288
2,294
2,141
1,887
2,720
2,164
2,148
1,890
1,429
1,038
1,282
1,567
2,357
1,826
2,428
2,358
3,106
2,979
3,876
4,613
3,998
3,748
4,346
4,669
5,209
3,263
3,797
5,001
4,161
4,989
5,062
5,353
4,766
4,868
3,822
4,096
4,090
4,396
4,740
4,180
5,194
4,146
3,566
2,993
2,651
3,489
3,549
5,351
4,350
2,778
3,719
3,615
3,395
3,879
2,772
2,7723,8793,3953,6153,7192,7784,3505,3513,5493,4892,6512,9933,5664,1465,1944,1804,7404,3964,0904,0963,8224,8684,7665,3535,0624,9894,1615,0013,7973,2635,2094,6694,3463,7483,9984,6133,8762,9793,1062,3582,4281,8262,3571,5671,2821,0381,4291,8902,1482,1642,7201,8872,1412,2942,2882,6032,4871,5862,4661,7041,4991,5651,5541,5471,6481,8702,1291,0601,2321,057950874745660922766626539456407376422572334453519471335359348425410471483400529558230318
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,008
5,246
5,314
2,003
1,057
1,352
1,660
1,383
1,793
2,145
2,618
2,582
2,256
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000002,2562,5822,6182,1451,7931,3831,6601,3521,0572,0035,3145,2465,00800000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,008
5,246
5,314
2,003
1,057
1,352
1,660
1,383
1,793
2,145
2,618
2,582
2,256
1,150
1,138
1,127
1,140
1,177
1,217
2,447
1,071
602
111
111
111
111
111
111
111
111
111
111
111
5
51111111111111111111111111111111116021,0712,4471,2171,1771,1401,1271,1381,1502,2562,5822,6182,1451,7931,3831,6601,3521,0572,0035,3145,2465,00800000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
215
128
260
254
262
225
226
176
188
163
287
233
369
417
376
267
353
372
289
299
438
481
566
703
852
576
658
782
857
973
1,158
997
2,097
1,843
1,627
1,531
1,476
1,487
1,419
1,631
1,868
1,353
1,786
1,889
1,976
1,979
1,849
1,761
1,950
1,643
1,539
1,392
1,312
778
1,174
1,448
1,631
1,120
1,716
1,673
1,869
1,476
1,598
1,666
1,446
1,462
1,614
1,811
2,272
1,443
1,456
1,913
1,767
1,610
1,594
1,580
1,463
1,581
1,355
1,378
1,488
1,599
2,212
1,736
1,795
1,812
1,495
1,520
1,829
1,783
0
2,517
0
0
0
0
0
0
0
00000002,51701,7831,8291,5201,4951,8121,7951,7362,2121,5991,4881,3781,3551,5811,4631,5801,5941,6101,7671,9131,4561,4432,2721,8111,6141,4621,4461,6661,5981,4761,8691,6731,7161,1201,6311,4481,1747781,3121,3921,5391,6431,9501,7611,8491,9791,9761,8891,7861,3531,8681,6311,4191,4871,4761,5311,6271,8432,0979971,158973857782658576852703566481438299289372353267376417369233287163188176226225262254260128215
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153
0
66
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205
159
111
57
50
0
0
0
143
145
0
0
0
0
0
0
0
0
0
0
143
143
326
904
520
676
844
853
915
699
902
1,346
931
1,507
1,244
1,075
640
856
1,156
1,418
1,316
1,501
1,197
1,078
743
1,064
1,285
1,192
555
1,482
0
2,570
0
0
0
0
0
0
0
00000002,57001,4825551,1921,2851,0647431,0781,1971,5011,3161,4181,1568566401,0751,2441,5079311,34690269991585384467652090432614314300000000001451430005057111159205000000000000000000001086601530000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,550
4,428
4,326
4,909
4,921
4,835
4,888
4,847
5,001
4,969
5,079
4,882
5,567
5,558
5,556
5,743
6,280
6,301
6,679
6,703
6,447
6,095
6,405
6,520
5,538
5,5386,5206,4056,0956,4476,7036,6796,3016,2805,7435,5565,5585,5674,8825,0794,9695,0014,8474,8884,8354,9214,9094,3264,4284,55000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28
27
28
30
215
220
237
278
730
752
758
793
795
726
463
493
488
498
518
497
516
536
553
559
516
534
553
542
419
416
406
392
401
389
374
387
369
355
326
331
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,558
0
0
0
0
0
0
0
0
0
0
0
000000000005,5580000000000000000000000000003313263553693873743894013924064164195425535345165595535365164975184984884934637267957937587527302782372202153028272800000000000000000000
> Total Stockholder Equity
1,068
1,275
1,168
1,300
1,404
1,303
1,168
1,185
1,299
1,335
1,245
1,282
1,337
1,470
1,417
1,553
1,320
1,810
2,067
2,180
2,379
2,354
2,646
2,614
1,325
1,086
943
2,917
2,303
8,300
7,458
6,062
7,159
5,792
5,370
5,245
5,997
5,410
6,538
5,195
5,487
5,598
5,286
5,226
4,902
4,774
5,429
4,953
4,198
3,842
3,933
3,712
5,549
5,496
6,414
7,329
8,788
9,133
10,158
10,503
10,272
10,082
10,929
11,099
11,647
11,371
11,710
12,233
12,131
14,697
18,310
18,481
10,354
10,268
10,692
10,540
10,537
9,980
11,948
11,554
6,619
7,044
8,215
16,714
18,556
22,198
23,814
24,745
24,939
23,461
23,365
22,643
24,624
27,226
27,756
28,022
28,297
28,900
31,065
31,06528,90028,29728,02227,75627,22624,62422,64323,36523,46124,93924,74523,81422,19818,55616,7148,2157,0446,61911,55411,9489,98010,53710,54010,69210,26810,35418,48118,31014,69712,13112,23311,71011,37111,64711,09910,92910,08210,27210,50310,1589,1338,7887,3296,4145,4965,5493,7123,9333,8424,1984,9535,4294,7744,9025,2265,2865,5985,4875,1956,5385,4105,9975,2455,3705,7927,1596,0627,4588,3002,3032,9179431,0861,3252,6142,6462,3542,3792,1802,0671,8101,3201,5531,4171,4701,3371,2821,2451,3351,2991,1851,1681,3031,4041,3001,1681,2751,068
   Retained Earnings -32,514-32,534-33,391-33,832-34,078-34,456-36,911-38,909-38,140-38,171-36,872-36,408-37,046-37,780-38,661-39,440-40,956-41,763-41,894-36,911-36,471-36,252-35,666-35,618-35,426-35,818-35,698-27,513-27,513-21,659-21,646-20,106-19,722-19,73000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CAD. All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-09-30. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue25,394
Cost of Revenue-10,002
Gross Profit15,39215,392
 
Operating Income (+$)
Gross Profit15,392
Operating Expense-21,489
Operating Income3,905-6,097
 
Operating Expense (+$)
Research Development2,125
Selling General Administrative8,879
Selling And Marketing Expenses-
Operating Expense21,48911,005
 
Net Interest Income (+$)
Interest Income688
Interest Expense-922
Other Finance Cost-0
Net Interest Income-234
 
Pretax Income (+$)
Operating Income3,905
Net Interest Income-234
Other Non-Operating Income Expenses-
Income Before Tax (EBT)3,6713,905
EBIT - interestExpense = -922
3,520
4,442
Interest Expense922
Earnings Before Interest and Taxes (EBIT)-4,593
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax3,671
Tax Provision-151
Net Income From Continuing Ops3,5203,520
Net Income3,520
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-234
 

Technical Analysis of Microbix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Microbix. The general trend of Microbix is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Microbix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Microbix Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Microbix Biosystems Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.237 < 0.237 < 0.24.

The bearish price targets are: 0.214 > 0.2 > 0.171.

Know someone who trades $MBXBF? Share this with them.πŸ‘‡

Microbix Biosystems Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Microbix Biosystems Inc.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Microbix Biosystems Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Microbix Biosystems Inc.. The current macd is -0.00647187.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Microbix price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Microbix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Microbix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Microbix Biosystems Inc. Daily Moving Average Convergence/Divergence (MACD) ChartMicrobix Biosystems Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Microbix Biosystems Inc.. The current adx is 10.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Microbix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Microbix Biosystems Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Microbix Biosystems Inc.. The current sar is 0.24049062.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Microbix Biosystems Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Microbix Biosystems Inc.. The current rsi is 35.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Microbix Biosystems Inc. Daily Relative Strength Index (RSI) ChartMicrobix Biosystems Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Microbix Biosystems Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Microbix price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Microbix Biosystems Inc. Daily Stochastic Oscillator ChartMicrobix Biosystems Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Microbix Biosystems Inc.. The current cci is -105.88663168.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Microbix Biosystems Inc. Daily Commodity Channel Index (CCI) ChartMicrobix Biosystems Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Microbix Biosystems Inc.. The current cmo is -26.27813766.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Microbix Biosystems Inc. Daily Chande Momentum Oscillator (CMO) ChartMicrobix Biosystems Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Microbix Biosystems Inc.. The current willr is -79.09090909.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Microbix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Microbix Biosystems Inc. Daily Williams %R ChartMicrobix Biosystems Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Microbix Biosystems Inc..

Microbix Biosystems Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Microbix Biosystems Inc.. The current atr is 0.00371024.

Microbix Biosystems Inc. Daily Average True Range (ATR) ChartMicrobix Biosystems Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Microbix Biosystems Inc.. The current obv is 372,537.

Microbix Biosystems Inc. Daily On-Balance Volume (OBV) ChartMicrobix Biosystems Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Microbix Biosystems Inc.. The current mfi is 18.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Microbix Biosystems Inc. Daily Money Flow Index (MFI) ChartMicrobix Biosystems Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Microbix Biosystems Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-29MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Microbix Biosystems Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Microbix Biosystems Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.654
Ma 20Greater thanMa 500.221
Ma 50Greater thanMa 1000.241
Ma 100Greater thanMa 2000.265
OpenGreater thanClose0.216
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Microbix with someone you think should read this too:
  • Are you bullish or bearish on Microbix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Microbix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Microbix Biosystems Inc.

I send you an email if I find something interesting about Microbix Biosystems Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Microbix Biosystems Inc..

Receive notifications about Microbix Biosystems Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.